Idarubicin and neutropenic sepsis Patient Reports February 12, 2012
Idarubicin Side Effects Report #5503254-3
Idarubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 16, 2007. Male patient, 69 years of age, weighting 152.8 lb, was diagnosed with multiple myeloma
, hyperuricaemia, nausea
and was treated with Idarubicin. After drug was administered, patient experienced the following side effects: cough, dyspnoea, malaise, neutropenic sepsis, overdose, white blood cell count decreased. Idarubicin dosage: unknown. During the same period patient was treated with DEXAMETHASONE, ALLOPURINOL, CYCLIZINE. Patient died on 01/09/2007.Idarubicin Side Effects Report #5346697-3
Idarubicin side effect was reported by a Health Professional from UNITED KINGDOM on May 24, 2007. Male patient, 36 years of age, was treated with Idarubicin. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, febrile neutropenia, multi-organ failure, neutropenic sepsis. Idarubicin dosage: unknown. During the same period patient was treated with CYTOSINE ARABINOSIDE, FLUDARABINE, FILGRASTIM. Patient died on 04/23/2007.
Idarubicin Side Effects Report #5428099-4
Idarubicin side effect was reported by a Health Professional from UNITED KINGDOM on Aug 16, 2007. Male patient, 36 years of age, was treated with Idarubicin. After drug was administered, patient experienced the following side effects: abdominal discomfort, acute myeloid leukaemia, febrile neutropenia, multi-organ failure, neutropenic sepsis. Idarubicin dosage: unknown. During the same period patient was treated with CYTARABINE, FILGRASTIM, FLUDARABINE PHOSPHATE. Patient was hospitalized. Patient died on 04/23/2007.
Idarubicin Side Effects Report #5536214-7
Idarubicin side effect was reported by a Health Professional from UNITED KINGDOM on Nov 27, 2007. Male patient, 36 years of age, was treated with Idarubicin. After drug was administered, patient experienced the following side effects: abdominal discomfort, acute myeloid leukaemia, febrile neutropenia, multi-organ failure, neutropenic sepsis, no therapeutic response. Idarubicin dosage: unknown. During the same period patient was treated with CYTARABINE, FLUDARABINE PHOSPHATE, NEUPOGEN. Patient was hospitalized. Patient died on 04/23/2007.
Idarubicin and neutropenic sepsis 